These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 35144674)

  • 21. Correlation of clinical signs and symptoms of Behçet's disease with platelet-to-lymphocyte ratio (PLR) and neutrophil-to-lymphocyte ratio (NLR).
    Shadmanfar S; Masoumi M; Davatchi F; Shahram F; Akhlaghi M; Faezi ST; Kavosi H; Parsaei A; Moradi S; Balasi J; Moqaddam ZR
    Immunol Res; 2021 Aug; 69(4):363-371. PubMed ID: 34109535
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Serum beta 2-microglobulin reflects disease activity in Behçet's disease.
    Aygündüz M; Bavbek N; Oztürk M; Kaftan O; Koşar A; Kirazli S
    Rheumatol Int; 2002 May; 22(1):5-8. PubMed ID: 12120912
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Vascular endothelial and basic fibroblast growth factor serum levels in patients with Behçet's disease.
    Erdem F; Gündoğdu M; Kiki I; Ali Sari R; Kiziltunç A
    Rheumatol Int; 2005 Oct; 25(8):599-603. PubMed ID: 15257411
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Do Pre-Reimplantation Erythrocyte Sedimentation Rate/C-Reactive Protein Cutoffs Guide Decision-Making in Prosthetic Joint Infection? Are We Flying Blind?
    Johnson NR; Rowe TM; Valenzeula MM; Scarola GT; Fehring TK
    J Arthroplasty; 2022 Feb; 37(2):347-352. PubMed ID: 34742874
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Possible Role of Regulatory B Cells in Different Behçet's Disease Phenotypes and Therapies: First Report from Egypt.
    Hetta HF; Mohamed AAA; Zahran AM; A Mahran S; My Sayed M; Ga Saleh M; Abdelazeem K; Batiha GE; Al-Rejaie S; Waheed Y; Muhammad K; M Hassanien M
    J Inflamm Res; 2021; 14():737-744. PubMed ID: 33727848
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Adenosine deaminase enzyme levels, their relation with disease activity, and the effect of colchicine on adenosine deaminase levels in patients with Behçet's disease.
    Calis M; Ates F; Yazici C; Kose K; Kirnap M; Demir M; Borlu M; Evereklioglu C
    Rheumatol Int; 2005 Aug; 25(6):452-6. PubMed ID: 15868151
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Homocysteine may involve in the pathogenesis of Behcet's disease by inducing inflammation.
    Kartal Durmazlar SP; Akgul A; Eskioglu F
    Mediators Inflamm; 2008; 2008():407972. PubMed ID: 19197380
    [TBL] [Abstract][Full Text] [Related]  

  • 28. C-reactive protein/albumin ratio as an indicator of disease activity in Behçet's disease and human leukocyte antigen-B27-associated uveitis.
    Kim M; Park YG; Park YH
    Graefes Arch Clin Exp Ophthalmol; 2021 Jul; 259(7):1985-1992. PubMed ID: 33929591
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Association between red blood cell distribution width and disease activity in patients with Behçet's disease.
    Aksoy ŞN; Savaş E; Sucu M; Kisacik B; Kul S; Zengin O
    J Int Med Res; 2015 Dec; 43(6):765-73. PubMed ID: 26359293
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Correlation of clinical signs and symptoms of Behçet's disease with mean platelet volume (MPV) and red cell distribution width (RDW).
    Masoumi M; Shadmanfar S; Davatchi F; Shahram F; Akhlagi M; Faezi T; Kavosi H; Moradi S; Balasi J
    Orphanet J Rare Dis; 2020 Oct; 15(1):297. PubMed ID: 33087144
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Different diagnostic performance of plasma fibrinogen and D-dimer in periprosthetic joint infection: a propensity score matched study.
    Chen X; Qian W; Weng X; Lin J; Jin J; Wang Y; Zhu S
    BMC Musculoskelet Disord; 2021 May; 22(1):422. PubMed ID: 33962585
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Thresholds for the 28-joint disease activity score (DAS28) using C-reactive protein are lower compared to DAS28 using erythrocyte sedimentation rate in early rheumatoid arthritis.
    Kuriya B; Schieir O; Lin D; Xiong J; Pope J; Boire G; Haraoui B; Thorne JC; Tin D; Hitchon C; Jamal S; Keystone E; Bykerk VP;
    Clin Exp Rheumatol; 2017; 35(5):799-803. PubMed ID: 28339365
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Ultrasonographic measurement of the vascular wall thickness and intima-media thickness in patients with Behçet's disease with symptoms or signs of vascular involvement: A cross-sectional study.
    Kaymaz S; Yilmaz H; Ufuk F; Ütebey AR; Çobankara V; Karasu U; Albayrak Yaşar C; Ulutaş F
    Arch Rheumatol; 2021 Jun; 36(2):258-266. PubMed ID: 34527931
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Value of combined measurement of C-reactive protein, erythrocyte sedimentation rate, lactate dehydrogenase and serum ferritin in etiological diagnosis of fever of unknown origin in children].
    Xie T; Pan JH; Zhang X
    Zhongguo Dang Dai Er Ke Za Zhi; 2015 Sep; 17(9):950-5. PubMed ID: 26412177
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Variation of red blood cell parameters in Behcet's disease: association with disease severity and vascular involvement.
    Cheng L; Li L; Liu C; Yan S; Chen H; Li H; Zhang F; Chen H; Li Y
    Clin Rheumatol; 2021 Apr; 40(4):1457-1464. PubMed ID: 32939568
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Vascular endothelial growth factor and monocyte chemoattractant protein-1 in Behçet's patients with venous thrombosis.
    Bozoglu E; Dinc A; Erdem H; Pay S; Simsek I; Kocar IH
    Clin Exp Rheumatol; 2005; 23(4 Suppl 38):S42-8. PubMed ID: 16273763
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Expression of a soluble triggering receptor expressed on myeloid cells-1 (sTREM-1) correlates with clinical disease activity in intestinal Behcet's disease.
    Jung YS; Kim SW; Yoon JY; Lee JH; Jeon SM; Hong SP; Kim TI; Kim WH; Cheon JH
    Inflamm Bowel Dis; 2011 Oct; 17(10):2130-7. PubMed ID: 21910175
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical Significance of Serum Bilirubin in Behçet's Disease.
    Koca TT
    J Transl Int Med; 2018 Dec; 6(4):185-188. PubMed ID: 30637206
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The predictive value of C-reactive protein and erythrocyte sedimentation rate for 18F-FDG PET/CT outcome in patients with fever and inflammation of unknown origin.
    Balink H; Veeger NJ; Bennink RJ; Slart RH; Holleman F; van Eck-Smit BL; Verberne HJ
    Nucl Med Commun; 2015 Jun; 36(6):604-9. PubMed ID: 25738560
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Serum interleukin-6, procalcitonin and C-reactive protein levels in subjects with active Behçet's disease.
    Adam B; Calikoglu E
    J Eur Acad Dermatol Venereol; 2004 May; 18(3):318-20. PubMed ID: 15096143
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.